ADIPOQ and obesity disorder: This is in keeping with the evidence that obesity decreases not only plasma adiponectin levels but also AdipoR1/R2 expression, thereby reducing adiponectin sensitivity and leading to insulin resistance, which in turn aggravates hyperinsulinemia [26].